IL6 and prostate carcinoma: Actually, CXCL13 was found to be positively correlated with IL-6 in prostate cancer, BPH and high-grade prostatic intraepithelial neoplasia [29], and involved in experimental autoimmune cystitis and interstitial cystitis [40].